Essential Pro study for routine hospital patients
Part of Heart & circulation clinical trials.
This trial is studying the Essential Pro device or treatment in patients who are already using it as part of their normal hospital care. The goal is to see how well it works in everyday practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently using Essential Pro as part of your hospital treatment
- Your doctor has prescribed Essential Pro according to the normal instructions
- You have signed a consent form agreeing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
This trial looks at how different types of drug-coated stents work in everyday care for people with blocked heart arteries. It may help doctors choose the best stent type to keep the artery open after treatment.
This trial is a registry that collects information from people who receive a heart artery procedure (percutaneous coronary intervention) at the study hospital. It mainly helps researchers understand outcomes and care patterns, and it only requires your consent to participate.
This study tracks patients with weakened heart function who undergo complex stent procedures (PCI) instead of open-heart surgery. Researchers will follow your progress to understand how well these procedures work in patients who are too sick for traditional bypass surgery.
This trial tests whether a small heart-support device called Impella CP helps protect your heart during complex coronary angioplasty (a procedure to open blocked heart arteries). You may qualify if you have weak heart function and specific patterns of blocked arteries that make the procedure higher risk.
This trial is a registry that collects health information from adults who undergo a heart procedure called coronary angioplasty. It may help researchers understand outcomes and improve care for future patients undergoing similar treatments.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.